Analyst Ratings for Millendo Therapeutics Inc. (MLND)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 4.3 / 10
Percentile Rank: 43%
Rating Score: 4.3 / 10
Percentile Rank: 43%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/6/2021 | Ladenburg Thalmann | Matthew Kaplan | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.69 (1.06) |
-37.28% | Details |
| 1/6/2021 | Leerink Partners | Joseph Schwartz | Downgrade | Market Perform (Outperform) |
2.00 (N/A) |
2.06 (1.06) |
-48.54% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
